<DOC>
	<DOCNO>NCT01417078</DOCNO>
	<brief_summary>The purpose study determine pharmacokinetics Diazepam Nasal Spray follow single dose epileptic patient experience seizure episode .</brief_summary>
	<brief_title>A Pharmacokinetic Study Single-Dose Diazepam Nasal Spray Adult Epileptic Patients Experiencing Seizure Episode</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Diazepam</mesh_term>
	<criteria>Provide sign informed consent study participation . General good health clinically significant unstable abnormality . Diagnosis epilepsy . Individuals receive warfarin ( Coumadin® ) dabigatran ( Pradaxa® ) . Use investigational drug within 30 day . Blood plasma donation within 30 day . Not willing unable tolerate blood draw .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>